Luzhu Biotech Records Stable Share Capital in September 2026, Affirms Sufficient Public Float

Bulletin Express

Oct 05

Beijing Luzhu Biotechnology Co., Ltd. (“Luzhu Biotech”) filed its Monthly Return for the period ended 30 September 2026, indicating no movements in either authorised/registered or issued share capital during the month.

Key data points • Authorised / registered share capital: 202.45 million ordinary H shares with a par value of RMB 1 each; unchanged from August.

• Issued share position: 202.45 million shares, comprising 198.91 million outstanding shares and 3.54 million treasury shares—both figures flat month-on-month.

• Public float: The company confirmed compliance with the Hong Kong Main Board’s minimum 25% public float requirement as at 30 September 2026.

• Capital activities: No share options, warrants, convertible securities, or other equity issuance arrangements were executed or outstanding.

The return, submitted on 5 October 2026 by Company Secretary Liu Siyu, confirms full adherence to all applicable listing rules and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1114354999"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1114354999\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1114354999?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-05 17:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114354999","market":"hk","top_or_hot":-1,"title":"Luzhu Biotech Records Stable Share Capital in September 2026, Affirms Sufficient Public Float","media":"Bulletin Express","content":"<p>Beijing Luzhu Biotechnology Co., Ltd. (“Luzhu Biotech”) filed its Monthly Return for the period ended 30 September 2026, indicating no movements in either authorised/registered or issued share capital during the month.</p>\n<p>Key data points  \n• Authorised / registered share capital: 202.45 million ordinary H shares with a par value of RMB 1 each; unchanged from August.</p>\n<p>• Issued share position: 202.45 million shares, comprising 198.91 million outstanding shares and 3.54 million treasury shares—both figures flat month-on-month.</p>\n<p>• Public float: The company confirmed compliance with the Hong Kong Main Board’s minimum 25% public float requirement as at 30 September 2026.</p>\n<p>• Capital activities: No share options, warrants, convertible securities, or other equity issuance arrangements were executed or outstanding.</p>\n<p>The return, submitted on 5 October 2026 by Company Secretary Liu Siyu, confirms full adherence to all applicable listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Luzhu Biotech Records Stable Share Capital in September 2026, Affirms Sufficient Public Float</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLuzhu Biotech Records Stable Share Capital in September 2026, Affirms Sufficient Public Float\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-10-05 17:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Luzhu Biotechnology Co., Ltd. (“Luzhu Biotech”) filed its Monthly Return for the period ended 30 September 2026, indicating no movements in either authorised/registered or issued share capital during the month.</p>\n<p>Key data points  \n• Authorised / registered share capital: 202.45 million ordinary H shares with a par value of RMB 1 each; unchanged from August.</p>\n<p>• Issued share position: 202.45 million shares, comprising 198.91 million outstanding shares and 3.54 million treasury shares—both figures flat month-on-month.</p>\n<p>• Public float: The company confirmed compliance with the Hong Kong Main Board’s minimum 25% public float requirement as at 30 September 2026.</p>\n<p>• Capital activities: No share options, warrants, convertible securities, or other equity issuance arrangements were executed or outstanding.</p>\n<p>The return, submitted on 5 October 2026 by Company Secretary Liu Siyu, confirms full adherence to all applicable listing rules and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02480","symbol_name":"绿竹生物-B","start_time":0,"source_url":"","article_id":"1114354999","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114354999","pubTimestamp":1791191320,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Luzhu Biotechnology Co., Ltd. (“Luzhu Biotech”) filed its Monthly Return for the period ended 30 September 2026, indicating no movements in either authorised/registered or issued share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02480":"绿竹生物-B"},"translate_title":"绿竹生物2026年9月股本稳定，确认充足的公众持股量","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02480":1},"content_text":"Beijing Luzhu Biotechnology Co., Ltd. (“Luzhu Biotech”) filed its Monthly Return for the period ended 30 September 2026, indicating no movements in either authorised/registered or issued share capital during the month.\nKey data points  \n• Authorised / registered share capital: 202.45 million ordinary H shares with a par value of RMB 1 each; unchanged from August.\n• Issued share position: 202.45 million shares, comprising 198.91 million outstanding shares and 3.54 million treasury shares—both figures flat month-on-month.\n• Public float: The company confirmed compliance with the Hong Kong Main Board’s minimum 25% public float requirement as at 30 September 2026.\n• Capital activities: No share options, warrants, convertible securities, or other equity issuance arrangements were executed or outstanding.\nThe return, submitted on 5 October 2026 by Company Secretary Liu Siyu, confirms full adherence to all applicable listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}